Opioid Prescriber Education Program
Activity Description:
As part of ongoing efforts to address the epidemic of opioid overdose deaths, New York State has established educational requirements in Public Health Law Article 33 §3309-a to raise healthcare provider awareness of the risks associated with prescribing and taking opioid pain medications. This program fulfills the mandate by providing education about state and federal requirements for prescribing controlled substances; pain management; appropriate prescribing; managing acute pain; palliative medicine; prevention, screening and signs of addiction; responses to abuse and addiction; and end of life care.
Additionally, this activity fulfills four out of eight hours of the Medication Access and Training Expansion (MATE) Act requirement for all DEA-registered practitioners to complete training on the treatment and management of patients with opioid or other substance use disorders.
Activity Type: Knowledge-based, online home-study
Learning Objectives:
- List the Federal and New York State (NYS) requirements for prescribing controlled substances
- Define the NYS Prescription Monitoring Program (PMP) and its purpose
- Describe NYS 7-day rules
- Describe the pathophysiology and general approaches for pain assessment in the ambulatory setting
- Describe approaches for managing acute pain and how they differ from approaches for managing chronic pain
- Outline evidence-based best practices for appropriate prescribing of opioid analgesics
- Identify risk factors for the development of OUD
- Describe screening tools and processes that may be used to identify signs of OUD
- Describe strategies to mitigate the risk of iatrogenic OUD
- Discuss treatment approaches based on whether the patient has chronic pain, OUD, both, or neither
- Explain harm reduction strategies
- Outline principles of and differences between palliative care and hospice care
- Describe the use of opioids in hospice and palliative care (e.g., cancer pain, dyspnea, methadone)
Target Audience: Prescribers with a Drug Enforcement Administration (DEA) number who are licensed to treat humans, and medical residents prescribing under a facility DEA number. This activity is also appropriate for pharmacists who care for patients using opioids.
Initial Release Date: 7/14/2023
Expiration Date: 7/13/2026
Cost and Registration: There is no fee associated with this program.
Activity Components for Continuing Education Credit: To obtain continuing education credit, complete the required materials. This continuing education activity contains a pre-test, video presentation, downloadable educational materials, post-test, and program evaluation. Credit will be awarded upon successful completion of the post-test activity, with a score of 70% or greater.
Once the course has been completed, prescribers may attest to their participation at: https://www.health.ny.gov/professionals/narcotic/mandatory_prescriber_education/neat.htm
Prescribers:
Accreditation: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
Certification: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this Enduring Material activity for a maximum of 4.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dentists:
The University at Buffalo, Continuing Dental Education is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between The University at Buffalo, Continuing Dental Education and The University at Buffalo School of Pharmacy and Pharmaceutical Sciences Office of Continuing Pharmacy Education.
UB Continuing Dental Education designates this activity for 4 credit hours, ADA/CERP continuing education credit.
Pharmacists:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE# 0044-0000-23-031-H08-P and will award 4.0 contact hours (0.40 CEUs) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor for those who complete all components of this activity. No partial credit is available.
Questions? Please email pharmacyce@buffalo.edu or call the Office of Continuing Pharmacy Education at (716) 645-2467.
The following planners, presenters and others have either indicated financial relationships with ineligible companies or that no financial relationships exist. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ACCME Standards for Integrity and Independence in Accredited Continuing Education
| The following individual has disclosed financial relationships: | |
| Author, Presenter: Romanth Waghmarae, MD, DABA, FACIP, FIPP | Speakers’ Bureau for Averitas Pharma, Inc. and Scilex Holding Company |
| All of the relevant financial relationships listed have been mitigated. | |
| The following planners/presenters/others do not have any relevant financial relationships with ineligible companies: | |
| Role in Activity | Name |
| Planner, Reviewer | Paige Allen, MPH |
| Planner, Author, Presenter | Edward M. Bednarczyk, PharmD, FACCP, FAPhA |
| Author, Presenter | Karl D. Fiebelkorn, BSPharm, RPh, MBA |
| Planner, Reviewer | Shirley Madewell |
| Planner | Marsha Nelson |
| Reviewer | Barbara Rogler, PharmD, MS |
| Activity Director, Planner, Reviewer, Author | Alexia Sroka, PharmD, BCPS |
| Planner, Reviewer, Author | Deborah Targoff, PharmD |
| Author, Presenter | Robert G. Wahler, Jr., PharmD, BCGP, CPE, FASCP |
| Planner | Juliet Warrick |
| Author, Presenter | Arthur Weissman, MD, FASAM |
No commercial support was received for this activity.
This program is supported by the Cooperative Agreement 6 NU17CE924974-03, funded by the Centers for Disease Control and Prevention and supported by the New York State Department of Health. The contents were developed in collaboration between the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and New York State Department of Health, and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
- Chrome, version 133 (64-bit) or higher
- Firefox, version 135 (64-bit) or higher
- Safari, version 18 (64-bit) or higher
- Edge, version 133 (64-bit) or higher
- Internet Explorer is NOT supported
- Smartphones have limited support. Use a desktop or laptop computer for the best experience.
- Chrome, version 133 (64-bit) or higher
- Safari, version 18 (64-bit) or higher
- Internet Speed: 5 Mbps
- Processor: Dual-core 2Ghz or higher
- Memory (RAM): 4GB
- Storage: Storage requirements are minimal unless materials are downloaded.
For questions about this activity, please email pharmacyce@buffalo.edu or call the Office of Continuing Pharmacy Education at (716) 645-2467.